Benzinga’s Top Pre-Market Gainers (AEO, FACT, ITMN, CYTK)

American Eagle Outfitters (NYSE: AEO) increased 6.71% to $18.30 in the pre-market session. American Eagle Outfitters announced yesterday that after an extensive evaluation and review of strategic alternatives, it plans to close its MARTIN+OSA concept, including all 28 stores and the online business. The 52-week trading range for AEO is $8.79 - $19.86. In the last six months, AEO has gained over 12%.

Facet Biotech Corporation (NASDAQ: FACT) climbed 66.32% to $26.96 in the pre-market session. Levi & Korsinsky is investigating the Board of Directors of Facet Biotech Corporation for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell FACT to Abbott Laboratories (NYSE: ABT). In the previous trading session, FACT closed at $16.21. Facet Biotech has surged over 152% in the last year.

InterMune, Inc. (NASDAQ: ITMN) jumped 66.31% to $38.75 in the pre-market session. InterMune reported yesterday that the Nasdaq halted trading of its common stock. A review panel for the U.S. Food and Drug Administration met yesterday to review and discuss InterMune's New Drug Application for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis. The 52-week trading range for ITMN is $10.48 - $25.37. InterMune closed at $23.30 in the last trading session.

Cytokinetics, Inc. (NASDAQ: CYTK) moved up 9.91% to $3.66 in the pre-market session. Cytokinetics announced that its fast skeletal muscle troponin activator, CK-2017357, has been granted orphan-drug designation by the U.S. Food and Drug Administration for the potential treatment of amyotrophic lateral sclerosis (ALS). The 52-week trading range for CYTK is $1.58 - $5.55. Cytokinetics closed at $3.33 in the previous trading session. CYTK has gained over 3% in the last six months.